Top performer TCG secures two commitments from Rhode Island

The Column Group is close to reaching its fundraising target of $600m apiece for its early-stage life science Fund V and later-stage Opportunity Fund III.

FundraisingInvestorsManagersNorth AmericaUSCommitmentsFundraisingLife SciencesPensions